Nucleus RadioPharma, the radiopharmaceutical-focused contract developing and manufacturing organisation founded by Eclipse ...

A new study published in the Nature journal of Mental Health Research shows powerful real-world evidence for the efficacy of ...

Despite being a rare disease impacting less than a million people worldwide, gMG treatment is an increasingly crowded market, ...

Nicox is on track to file for approval of its NCX 470 therapy for eyesight-robbing disease glaucoma after it showed efficacy in a second pivotal trial. The positive data from the Phase 3 Denali ...

HHS Secretary Kennedy adds yet another layer of scrutiny to childhood vaccines with the re-establishment of a task force disbanded in the 1990s.

Hundreds of current and former workers at the Department of Health and Human Services (HHS) have penned a letter to Robert F Kennedy Jr, asking him to stop spreading misinformation that is ...

Targovax interviewed by pharmaphorum said the market for oncolytic viruses is set to get increasingly crowded in the future as pharma tries to use the approach to improve efficacy of checkpoint ...

This month’s executive moves in the agency, consultancy, and investor sectors reflect a growing emphasis on strategic leadership, commercial expansion, and specialised expertise in life sciences. From ...

After UK Health Secretary Wes Streeting sent a letter to the pharma industry, warning that he would withdraw from ...

Twin Health has raised another $53 million to fund its 'digital twin' platform, which provides a model of a patient's unique ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Suzanne Aitken, SVP of managed access at Clinigen, ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...